Taro Pharmaceutical Industries Ltd reports results for the quarter ended in December - Earnings Summary

Taro Pharmaceutical Industries

26/01/2024 06:22

* Taro Pharmaceutical Industries Ltd  TARO.N  reported
quarterly
adjusted earnings of 54 cents​​ per share for the quarter ended
in December, higher than the same quarter last year, when the
company reported EPS of 19 cents.  The lone analyst forecast for
the quarter was for earnings of 30 cents per share. 
    * Revenue rose 12.9% to $157.15 million from a year ago;
analysts
expected $154.91 million. 
    * Taro Pharmaceutical Industries Ltd's reported EPS for the
quarter was 54 cents​.
    * The company reported quarterly net income of $20.21
million.
    * Taro Pharmaceutical Industries Ltd shares had risen
by 3.7% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 30.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "hold"

Wall Street's median 12-month price target for Taro
Pharmaceutical Industries Ltd is $43.00 
This summary was machine generated from LSEG data January 26 at
06:22 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.30           0.54           Beat
 Sep. 30 2023      0.18           0.38           Beat
 Jun. 30 2023      0.31           0.40           Beat
 Mar. 31 2023      0.23           0.18           Missed